About Cefa-Cilinas Biotics
Cefa-Cilinas Biotics is a Chemicals & Materials company based in Aurangabad (India) founded in 2012. It manufactures pharmaceutical APIs, intermediates, and specialty chemicals for export. It operates on a B2B model in Chemicals & Materials and Healthcare sectors. Its Indian entity Cefa-Cilinas Biotics Private Limited reported revenue of ₹3.25 Cr. Cefa-Cilinas Biotics offers products and services including Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives. Its focus areas include Chemicals, Speciality Chemicals, Derivatives and Iodine Derivatives. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Cefa-Cilinas Biotics Pvt. Ltd., based in Aurangabad, India, specializes in producing pharmaceutical active ingredients and intermediates such as Amlodipine and Cetirizine APIs. The company focuses on high-quality manufacturing of chemicals, including iodine and acetophenone derivatives, adhering to industry standards. They export products like specialty chemicals and agro ingredients to global clients, emphasizing effective quality control and customer service.
- Headquarters Aurangabad, India
- SectorsChemicals & MaterialsHealthcare
- Email••••••••
- Phone•••• ••••
- Website cefacilinas.com
- Legal Name Cefa-Cilinas Biotics Private Limited
- Date of Incorporation 12 Mar, 2016
- Jurisdiction Aurangabad, Maharashtra, India
- Annual Revenue₹3.25 Cr
FY 2024 · -34% YoY
- Net Profit₹82.5 Lakh
FY 2024 · 25% margin
- EBITDA₹97.7 Lakh
FY 2024 · 30% margin
Associated legal entities of Cefa-Cilinas Biotics
Cefa-Cilinas Biotics operates through Cefa-Cilinas Biotics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2024) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Cefa-Cilinas Biotics Private Limited CIN U24296MH2016PTC274279 | Active | 12 Mar 2016 | Aurangabad, Maharashtra | ₹3.3 Cr | 2 | View details |
Products & Services of Cefa-Cilinas Biotics
Cefa-Cilinas Biotics offers a comprehensive portfolio of products and services, including Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives.
Active ingredient used in blood pressure medications for treatment.
Antihistamine compound for allergy relief and symptom management.
Nonsteroidal anti-inflammatory drug for pain and fever reduction.
Chemical compounds used in pharmaceutical and industrial applications.
Intermediates for synthesis in drug and chemical manufacturing processes.
Board of directors of Cefa-Cilinas Biotics Private Limited (Cefa-Cilinas Biotics)
Cefa-Cilinas Biotics Private Limited is the primary company behind Cefa-Cilinas Biotics. The board of Cefa-Cilinas Biotics Private Limited currently have 2 directors; the longest-serving is Dhanraj Govind Rathod, appointed in 2016. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dhanraj Govind Rathod DIN 07448993 | Managing Director | 12 Mar 2016 | 10 yrs 7 mo | Cefa-Cilinas Biotics Private Limited |
| Arjun Govind Rathod DIN 10044891 | Director | 07 Feb 2023 | 3 yrs 8 mo | Cefa-Cilinas Biotics Private Limited |
Financials of Cefa-Cilinas Biotics
Figures of Cefa-Cilinas Biotics Private Limited, the primary company behind Cefa-Cilinas Biotics, for FY 2024. Revenue was ₹3.25 Cr (-34% year on year). Net profit was ₹82.5 Lakh (25% margin). EBITDA was ₹97.7 Lakh (30% margin). Revenue has grown at a compounded annual rate of +31% over three years and +11% over five years.
- ₹3.25 CrRevenue · FY 2024 · -34% YoY
- ₹82.5 LakhNet profit · 25% margin
- ₹97.7 LakhEBITDA · 30% margin
- ₹2.00 CrPaid-up capital
- +31%Revenue CAGR, 3 years
- +11%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Cefa-Cilinas Biotics Private Limited are on its company page.
Detailed financial statements for Cefa-Cilinas Biotics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Cefa-Cilinas Biotics
Cefa-Cilinas Biotics has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Cefa-Cilinas Biotics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Petrochemicals & Derivatives
3 companies that operate in the same segment as Cefa-Cilinas Biotics (Petrochemicals & Derivatives) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Produces and supplies specialty chemicals for energy, petrochemicals, and industrial applications worldwide. | 1992 | Mumbai, Maharashtra, India | USD 479.49 M | 976 | ||
Polybutene-based petrochemicals are produced by the company. | 1990 | Chennai, Tamil Nadu, India | USD 62.67 M | 194 | ||
Calcined petroleum coke, coal tar, and specialty chemicals are produced. | 1974 | Hyderabad, Telangana, India | USD 1.88 B | 2,390 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Cefa-Cilinas Biotics
Cefa-Cilinas Biotics was founded in 2012.
Cefa-Cilinas Biotics is headquartered in Aurangabad, India. It is registered at Aurangabad, Maharashtra, India.
The primary company behind Cefa-Cilinas Biotics, Cefa-Cilinas Biotics Private Limited, reported revenue of ₹3.25 Cr for FY 2024, down 34% year on year.
Cefa-Cilinas Biotics Pvt. Ltd., based in Aurangabad, India, specializes in producing pharmaceutical active ingredients and intermediates such as Amlodipine and Cetirizine APIs. The company focuses on high-quality manufacturing of chemicals, including iodine and acetophenone derivatives, adhering to industry standards. They export products like specialty chemicals and agro ingredients to global clients, emphasizing effective quality control and customer service.
Cefa-Cilinas Biotics's top competitors include Laurus Labs, Symbiotec and SeQuent.
Cefa-Cilinas Biotics offers Amlodipine Base API, Cetirizine Dihydrochloride API, Ibuprofen API, Iodine Derivatives, and Acetophenone Derivatives.
Cefa-Cilinas Biotics operates through Cefa-Cilinas Biotics Private Limited.
The legal entities of Cefa-Cilinas Biotics currently have 2 directors, including Dhanraj Govind Rathod, Arjun Govind Rathod.